The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 825 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Follow-Up Questions
TOI 주식의 가격 성능은 어떻습니까?
TOI의 현재 가격은 $3.19이며, 전 거래일에 increased 2.27% 하였습니다.
Oncology Institute Inc의 주요 사업 주제나 업종은 무엇입니까?
Oncology Institute Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Oncology Institute Inc의 시가총액은 얼마입니까?
Oncology Institute Inc의 현재 시가총액은 $298.3M입니다
Oncology Institute Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 4명의 분석가가 Oncology Institute Inc에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 4명의 매수, 1명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다
